🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not A

    NOT-TR-22-016

    Tiina K. Urv, Ph.D.

    Opening date 24 Mar 2022, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-TR-22-016

    Opportunity Category: Discretionary

    Cost Sharing or Matching Requirement: No

    Posted Date: Mar 24, 2022 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 1000000

    Eligible Applicants: Public housing authorities/Indian housing authorities,Small businesses,County governments,Native American tribal organizations (other than Federally recognized tribal governments),Public and State controlled institutions of higher education,Others (see text field entitled "Additional Information on Eligibility" for clarification),Independent school districts,Native American tribal governments (Federally recognized),State governments,For profit organizations other than small businesses,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Private institutions of higher education

    Description: The National Center for Advancing Translational Sciences (NCATS) intends to publish a Funding Opportunity Announcement (FOA) to advance the diagnosis, management, and treatment of rare diseases). The Rare Diseases Clinical Research Network (RDCRN) consists of the Rare Diseases Clinical Research Consortia (RDCRC) that promote highly collaborative, multi-site, patient-centric, translational, and clinical research and the Data Management and Coordinating Center (DMCC), which will facilitate and support the activities of each of the Rare Diseases Clinical Research Consortia (RDCRC) along with trans-network activities that broadly facilitate the advancement of rare disease research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in 2024, with an estimated award date in 2025. This FOA will utilize the U2Cactivity code, which supports specialized centers through multi-project cooperative agreement awards to support research activities with substantial involvement from NIH program staff. Details of the planned FOA are provided below.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept